Responsiveness to exercise training in juvenile dermatomyositis: A twin case study

BMC Musculoskeletal Disorders

Volumn 11, Issue , 2010, Pages

  Omori, Clarissa ^a   Prado, Danilo M L ^a   Gualano, Bruno ^a   Sallum, Adriana M E ^a   Sá Pinto, Ana L ^a   Roschel, Hamilton ^a   Perondi, Maria B ^a   Silva, Clovis A A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCLE ENZYME; PREDNISONE;

AEROBIC EXERCISE; ANAEROBIC THRESHOLD; ARTICLE; CASE REPORT; CHILD; DERMATOMYOSITIS; DISEASE ACTIVITY; EXERCISE; FEMALE; FUNCTION TEST; HAND GRIP; HUMAN; INFLAMMATION; JUVENILE DERMATOMYOSITIS; MONOZYGOTIC TWINS; MUSCLE FUNCTION; MUSCLE INJURY; MUSCLE STRENGTH; MUSCLE TRAINING; PATIENT ASSESSMENT; QUALITY OF LIFE; SCHOOL CHILD; CASE CONTROL STUDY; DISABILITY; EXERCISE TOLERANCE; KINESIOTHERAPY; LONGITUDINAL STUDY; MUSCLE WEAKNESS; PATHOPHYSIOLOGY; PHYSIOLOGY; RESISTANCE TRAINING; SKELETAL MUSCLE; TREATMENT OUTCOME; TWINS;

CASE-CONTROL STUDIES; CHILD; DERMATOMYOSITIS; DISABILITY EVALUATION; EXERCISE; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MUSCLE WEAKNESS; MUSCLE, SKELETAL; QUALITY OF LIFE; RESISTANCE TRAINING; TREATMENT OUTCOME;

EID: 78649320485     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-11-270     Document Type: Article

References (27)

1. Juvenile dermatomyositis: clinical, laboratorial, histological, therapeutical and evolutive parameters of 35 patients. AM Sallum MH Kiss S Sachetti MB Resende KC Moutinho S Carvalho Mde CA Silva SK Marie, Arq Neuropsiquiatr 2002 60 4 889 899 12563375
2. Risk factors associated with calcinosis of juvenile dermatomyositis. AM Sallum FC Pivato U Doria-Filho NE Aikawa BL Liphaus SK Marie CA Silva, J Pediatr (Rio J) 2008 84 1 68 74 10.1590/S0021-75572008000100012 18185899
3. Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use. RA Santiago CA Silva VF Caparbo AM Sallum RM Pereira, Scand J Rheumatol 2008 37 1 40 47 10.1080/03009740701687226 18189194
4. A Brazilian registry of juvenile dermatomyositis: onset features and classification of 189 cases. JO Sato AM Sallum VP Ferriani R Marini SB Sacchetti EM Okuda JF Carvalho RM Pereira CA Len MT Terreri,, et al. Clin Exp Rheumatol 2009 27 6 1031 1038 20149327
5. Aerobic exercise capacity in patients with juvenile dermatomyositis. T Takken N Spermon PJ Helders AB Prakken J Van Der Net, J Rheumatol 2003 30 5 1075 1080 12734909
6. Anaerobic exercise capacity in patients with juvenile-onset idiopathic inflammatory myopathies. T Takken J van der Net PJ Helders, Arthritis Rheum 2005 53 2 173 177 10.1002/art.21066 15818720
7. Responsiveness of exercise parameters in children with inflammatory myositis. T Takken J van der Net RH Engelbert S Pater PJ Helders, Arthritis Rheum 2008 59 1 59 64 10.1002/art.23250 18163418
8. Juvenile idiopathic inflammatory myopathies: the value of magnetic resonance imaging in the detection of muscle involvement. MO Hilario H Yamashita D Lutti C Len MT Terreri H Lederman, Sao Paulo Med J 2000 118 2 35 40 10.1590/S1516-31802000000200002 10772694
9. Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme. GF Wiesinger M Quittan M Aringer A Seeber B Volc-Platzer J Smolen W Graninger, Br J Rheumatol 1998 37 2 196 200 10.1093/rheumatology/37.2.196 9569076
10. Benefit of 6 months long-term physical training in polymyositis/ dermatomyositis patients. GF Wiesinger M Quittan M Graninger A Seeber G Ebenbichler B Sturm K Kerschan J Smolen W Graninger, Br J Rheumatol 1998 37 12 1338 1342 10.1093/rheumatology/37.12.1338 9973161
11. Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis. H Alexanderson M Dastmalchi M Esbjornsson-Liljedahl CH Opava IE Lundberg, Arthritis Rheum 2007 57 5 768 777 10.1002/art.22780 17530676
12. The safety of a resistive home exercise program in patients with recent onset active polymyositis or dermatomyositis. H Alexanderson CH Stenstrom G Jenner I Lundberg, Scand J Rheumatol 2000 29 5 295 301 10.1080/030097400447679 11093595
13. Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction. S Arnardottir H Alexanderson IE Lundberg K Borg, J Rehabil Med 2003 35 1 31 35 10.1080/16501970306110 12610846
14. Resistance training with vascular occlusion in inclusion body myositis: a case study. B Gualano M Neves Jr FR Lima AL Pinto G Laurentino C Borges L Baptista GG Artioli MS Aoki A Moriscot,, et al. Med Sci Sports Exerc 42 2 250 254 19927034
15. Polymyositis and dermatomyositis (second of two parts). A Bohan JB Peter, N Engl J Med 1975 292 8 403 407 10.1056/NEJM197502202920807 1089199
16. ASEP procedures recommendation I: accurate assessment of muscular strength and power. LE Brown JP Weir, Journal of Exercise Physiologyonline 2001 4 3 1 21
17. Validity and reliability of the timed-stands test for patients with rheumatoid arthritis and other chronic diseases. KL Newcomer HE Krug ML Mahowald, J Rheumatol 1993 20 1 21 27 8441160
18. Efficacy and safety of concurrent training in systemic sclerosis. ALS Pinto NC Oliveira B Gualano RBC Souza VP de Salles GG Artioli DM Prado FR Lima, J Strength and Cond Res
19. Paediatric Rheumatology International Trials Organisation. The Brazilian version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). CS Machado N Ruperto CH Silva VP Ferriani I Roscoe LM Campos SK Oliveira MH Kiss BE Bica F Sztajnbok,, et al. Clin Exp Rheumatol 2001 19 4 Suppl 23 25 29 11510326
20. Physical therapy in infantili paralysis. AT Legg JB Merril, Principles and paractice of physical therapy 1932
21. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. DJ Lovell CB Lindsley RM Rennebohm SH Ballinger SL Bowyer EH Giannini JE Hicks JE Levinson R Mier LM Pachman,, et al. Arthritis Rheum 1999 42 10 2213 2219 10.1002/1529-0131(199910)42:10<2213::AID-ANR25 3.0.CO;2-8 10524696
22. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group. LG Rider BM Feldman MD Perez RM Rennebohm CB Lindsley LS Zemel CA Wallace SH Ballinger SL Bowyer AM Reed,, et al. Arthritis Rheum 1997 40 11 1976 1983 10.1002/art.1780401109 9365086
23. The reliability of an aerobic and an anaerobic exercise tolerance test in patients with juvenile onset dermatomyositis. T Takken J van der Net PJ Helders, J Rheumatol 2005 32 4 734 739 15801033
24. The possible role of physical exercise on the treatment of idiopathic inflammatory myopathies. V de Salles Painelli B Gualano GG Artioli AL de Sa Pinto E Bonfa AH Lancha Junior FR Lima, Autoimmun Rev 2009 8 5 355 359 10.1016/j.autrev.2008.11.008 19041955
25. Evidence for prescribing exercise as therapy in chronic disease. BK Pedersen B Saltin, Scand J Med Sci Sports 2006 16 Suppl 1 3 63 10.1111/j.1600-0838.2006.00520.x 16451303
26. Exercise in pediatric rheumatic diseases. SE Klepper, Curr Opin Rheumatol 2008 20 5 619 624 10.1097/BOR.0b013e32830634ee 18698188
27. Quantitative assessments of the effects of a single exercise session on muscles in juvenile dermatomyositis. SM Maillard R Jones CM Owens C Pilkington PM Woo LR Wedderburn KJ Murray, Arthritis Rheum 2005 53 4 558 564 10.1002/art.21332 16082634